Therapeutic Candidates
Learn how we are advancing our pipeline of cardiometabolic and obesity therapeutics, developed and optimized with our AI Drug Discovery Platform
Obesity and Cardiometabolic Diseases
Developing first-in-class and best-in-class therapeutics for obesity, diabetes, and other metabolic diseases
Therapeutic Pipeline
RAPIDLY ADVANCING HARD-TO-ENGINEER ANTIBODIES
Discovery Platform
From precision antibody identification and optimization to tailored bispecifics and a cutting-edge masking technology
Partner with iBio
License our discovery platform or collaborate with us to advance our high-value pipeline assets
The Expertise Behind the AI
Meet the team driving iBio’s powerful tech stack for drug discovery
